ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

quant Healthcare Fund

QUANT quant Mutual Fund Aug 2023 — Sep 2026 26 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹286 CrAt NSE closes, Sep 2026
Companies held1313 with an NSE price
Top 10 holdings95.3%Of the equity shown here
Largest holding14.4%GlaxoSmithKline Pharmaceuticals Limited
12-month turnover—Not enough comparable months

Days to sell half: 7.2 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Dec 2024). Takes days, not hours, to unwind. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

23 priced months, Aug 2023 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

95.3% now, 86.3% in Sep 2025 · highest 99.6%, lowest 68.8%

Companies held

13 now, 14 in Sep 2025 · largest single holding 14.4% of equity

3 month(s) left out because under 90% of the companies held had an NSE price that month.

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. quant Consumption Fundquant · 5 shared24.5%
  2. quant Aggressive Hybrid Fundquant · 2 shared21.5%
  3. quant Manufacturing Fundquant · 6 shared19.2%
  4. Bandhan Healthcare FundBandhan · 7 shared18.9%
  5. quant Multi Cap Fundquant · 8 shared18.4%
  6. quant Mid Cap Fundquant · 5 shared18.1%
  7. Bajaj Finserv Healthcare FundBajaj Finserv · 7 shared17.2%
  8. quant Flexi Cap Fundquant · 5 shared15.4%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 4 Companies added
Complete exits 2 Companies sold out
Increases 1 More shares than last month
Reductions 3 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 14.40% 41.14 Cr 0.01 Cr Mar 2026 (6 mo)
Zydus Lifesciences Limited Healthcare Mid Cap 13.94% 39.84 Cr 0.03 Cr Aug 2026 (2 mo)
Strides Pharma Science Limited Healthcare Small Cap 13.43% 38.36 Cr 0.03 Cr Apr 2026 (5 mo)
Pfizer Limited Healthcare Small Cap 10.95% 31.28 Cr 80,707 May 2024 (19 mo)
Alivus Life Sciences Limited Not classified Small Cap 9.23% 26.38 Cr 0.02 Cr Jul 2024 (18 mo)
IPCA Laboratories Limited Healthcare Mid Cap 8.88% 25.39 Cr 0.01 Cr Jul 2026 (3 mo)
Aurobindo Pharma Limited Healthcare Mid Cap 7.56% 21.60 Cr 0.01 Cr Feb 2024 (22 mo)
Zydus Wellness Limited Fast Moving Consumer Goods Small Cap 7.28% 20.79 Cr 0.04 Cr Jul 2024 (18 mo)
Colgate Palmolive (India) Limited Fast Moving Consumer Goods Mid Cap 5.13% 14.64 Cr 83,050 Sep 2026 (1 mo)
Natco Pharma Limited Healthcare Small Cap 4.47% 12.78 Cr 0.02 Cr Sep 2026 (1 mo)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 3.47% 9.90 Cr 80,322 Sep 2026 (1 mo)
LG Electronics India Limited Consumer Durables Large Cap 0.88% 2.52 Cr 14,600 Sep 2026 (1 mo)
Sumitomo Chemical India Limited Chemicals Small Cap 0.39% 1.11 Cr 25,514 Jul 2026 (3 mo)

Half of its current holdings have been held for 3 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
SMS Pharmaceuticals Limited Sep 2026 ▼ Complete exit -0.08 Cr
Strides Pharma Science Limited Sep 2026 ▲ Increasing +0.02 Cr
Concord Biotech Limited Sep 2026 ▼ Complete exit -0.02 Cr
Natco Pharma Limited Sep 2026 ▲ New position +0.02 Cr
Colgate Palmolive (India) Limited Sep 2026 ▲ New position +83,050
Dr. Reddy's Laboratories Limited Sep 2026 ▲ New position +80,322
Alivus Life Sciences Limited Sep 2026 ▼ Reducing -55,050
Zydus Wellness Limited Sep 2026 ▼ Reducing -50,442
LG Electronics India Limited Sep 2026 ▲ New position +14,600
IPCA Laboratories Limited Sep 2026 ▼ Reducing -3,092
HFCL LIMITED Aug 2026 ▼ Complete exit -0.16 Cr
Aster DM Quality Care Limited Aug 2026 ▼ Complete exit -0.04 Cr
Zydus Lifesciences Limited Aug 2026 ▲ New position +0.03 Cr
Zydus Wellness Limited Aug 2026 ▼ Reducing -0.02 Cr
Concord Biotech Limited Aug 2026 ▼ Reducing -61,613
Pfizer Limited Aug 2026 ▲ Increasing +32,753
HFCL LIMITED Jul 2026 ▼ Reducing -0.04 Cr
IPCA Laboratories Limited Jul 2026 ▲ New position +0.01 Cr
GlaxoSmithKline Pharmaceuticals Limited Jul 2026 ▲ Increasing +0.01 Cr
Max Healthcare Institute Limited Jul 2026 ▼ Complete exit -70,148
Sumitomo Chemical India Limited Jul 2026 ▲ New position +25,514
HFCL LIMITED Apr 2026 ▲ New position +0.22 Cr
SMS Pharmaceuticals Limited Apr 2026 ▼ Reducing -0.01 Cr
Concord Biotech Limited Apr 2026 ▼ Complete exit -83,472
Anthem Biosciences Limited Apr 2026 ▼ Reducing -38,175
Adani Enterprises Limited Apr 2026 ▼ Complete exit -11,399
Strides Pharma Science Limited Apr 2026 ▲ New position +10,138
HDFC Life Insurance Company Limited Oct 2025 ▼ Complete exit -0.03 Cr
Aster DM Quality Care Limited Oct 2025 ▼ Reducing -0.02 Cr
RPG Life Sciences Limited Oct 2025 ▼ Complete exit -0.02 Cr
Adani Enterprises Limited Oct 2025 ▲ New position +94,996
Godrej Properties Limited Oct 2025 ▲ New position +47,015
SMS Pharmaceuticals Limited Oct 2025 ▲ Increasing +43,932
Divi's Laboratories Limited Oct 2025 ▲ New position +20,424
Zydus Lifesciences Limited Apr 2025 ▼ Complete exit -0.03 Cr
IPCA Laboratories Limited Apr 2025 ▼ Complete exit -0.02 Cr
SMS Pharmaceuticals Limited Apr 2025 ▲ Increasing +0.02 Cr
Lupin Limited Apr 2025 ▲ New position +56,976
Divi's Laboratories Limited Apr 2025 ▲ Increasing +1,073
Reliance Industries Limited Feb 2025 ▼ Reducing -24,390
Pfizer Limited Feb 2025 ▼ Reducing -9,115
RPG Life Sciences Limited Feb 2025 ▼ Reducing -2,538
Suven Life Sciences Limited Jan 2025 ▼ Complete exit -0.08 Cr
Aarti Pharmalabs Limited Jan 2025 ▼ Complete exit -0.03 Cr
GlaxoSmithKline Pharmaceuticals Limited Jan 2025 ▼ Complete exit -0.01 Cr
Divi's Laboratories Limited Jan 2025 ▲ New position +61,300
Torrent Pharmaceuticals Limited Jan 2025 ▲ Increasing +52,900
Thyrocare Technologies Limited Jan 2025 ▼ Complete exit -40,794
Alembic Pharmaceuticals Limited Jan 2025 ▼ Complete exit -40,380
Acutaas Chemicals Limited Jan 2025 ▼ Complete exit -17,566
IPCA Laboratories Limited Jan 2025 ▲ Increasing +11,800
Zydus Lifesciences Limited Jan 2025 ▲ Increasing +11,174
Sanofi Consumer Healthcare India Limited Jan 2025 ▼ Complete exit -7,900
Viyash Scientific Limited Oct 2024 ▲ Increasing +0.02 Cr
Thyrocare Technologies Limited Oct 2024 ▲ New position +40,794
Torrent Pharmaceuticals Limited Oct 2024 ▲ New position +34,300
Divi's Laboratories Limited Oct 2024 ▼ Reducing -19,051
Acutaas Chemicals Limited Oct 2024 ▲ New position +12,500
Alivus Life Sciences Limited Oct 2024 ▲ Increasing +184
Dishman Carbogen Amcis Limited May 2024 ▼ Complete exit -0.06 Cr
Indoco Remedies Limited May 2024 ▼ Complete exit -0.03 Cr
Jubilant Pharmova Limited May 2024 ▼ Complete exit -0.03 Cr
Zydus Lifesciences Limited May 2024 ▲ New position +0.02 Cr
Kopran Limited May 2024 ▼ Complete exit -0.01 Cr
Aarti Pharmalabs Limited May 2024 ▲ Increasing +0.01 Cr
Reliance Industries Limited May 2024 ▼ Complete exit -89,350
Aster DM Quality Care Limited May 2024 ▲ New position +86,164
Pfizer Limited May 2024 ▲ New position +54,346
Dr. Reddy's Laboratories Limited May 2024 ▲ New position +25,000
Aurobindo Pharma Limited May 2024 ▼ Reducing -6,200
GlaxoSmithKline Pharmaceuticals Limited May 2024 ▼ Reducing -5,000
Indraprastha Medical Corporation Limited Apr 2024 ▲ New position +0.07 Cr
Metropolis Healthcare Limited Apr 2024 ▼ Complete exit -85,000
GlaxoSmithKline Pharmaceuticals Limited Apr 2024 ▲ Increasing +60,000
Biocon Limited Mar 2024 ▼ Complete exit -0.07 Cr
SMS Pharmaceuticals Limited Mar 2024 ▲ New position +0.06 Cr
Gujarat Themis Biosyn Limited Mar 2024 ▲ New position +0.03 Cr
Kopran Limited Mar 2024 ▲ New position +0.01 Cr
Kovai Medical Center & Hospital Limited Mar 2024 ▲ Increasing +4,100
Dishman Carbogen Amcis Limited Feb 2024 ▲ New position +0.06 Cr
Aurobindo Pharma Limited Feb 2024 ▲ New position +0.02 Cr
Sun Pharmaceutical Industries Limited Feb 2024 ▼ Complete exit -0.01 Cr
Poly Medicure Limited Feb 2024 ▲ Increasing +0.01 Cr
Metropolis Healthcare Limited Feb 2024 ▲ New position +85,000
Kovai Medical Center & Hospital Limited Feb 2024 ▲ New position +35,300
Reliance Industries Limited Feb 2024 ▲ Increasing +8,000
Brooks Laboratories Limited Nov 2023 ▲ Increasing +0.01 Cr
Kopran Limited Nov 2023 ▼ Complete exit -0.01 Cr
Granules India Limited Nov 2023 ▲ Increasing +70,000
Alembic Pharmaceuticals Limited Nov 2023 ▼ Complete exit -52,000
Life Insurance Corporation Of India Nov 2023 ▲ New position +45,000
Aster DM Quality Care Limited Nov 2023 ▼ Reducing -2,600

Changes compare consecutive month-end disclosures for this portfolio only.